Cytocore Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2014 to a ratio of 7.27, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the third quarter 2014. Average receivable collection period, for the Cytocore Inc in Sep 30 2014 quarter, has decreased to 50 days, compared to 54 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 206 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1781 to 2459.

What is Receivable Turnover Ratio?
What is Cytocore Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CYOE Receivables Turnover Ratio	(Sep 30 2014) III. Quarter	(Jun 30 2014) II. Quarter	(Mar 31 2014) I. Quarter	(Dec 31 2013) IV. Quarter	(Sep 30 2013) III. Quarter
Y / Y Receivable Change	15611.11 %	14123.08 %	-68 %	-92.54 %	-94.61 %
Y / Y Revenue Change	55600 %	79275 %	-72.73 %	-42.86 %	-91.8 %
Receivable Turnover Ratio (TTM)	7.27	6.8	1.6	1.68	0.6
CYOE's Total Ranking	# 2459	# 1781	# 1780	# 1780	# 1780
Accounts Receivable average collection period days	50	54	228	217	612
Seq. Receivable Change	-23.53 %	23012.5 %	-20 %	11.11 %	-30.77 %
Seq. Revenue Change	-12.28 %	105733.33 %	-25 %	-20 %	25 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 15
Healthcare Sector	# 207
Overall Market	# 2459

Receivable Turnover Ratio Statistics
High	Average	Low
0.76	0.52	0.24
(Mar 31 2013)		(Sep 30 2013)

CYOE Company Profile • Back to CYOE Efficiency Comparisons • Compare CYOE Receivables Turnover Ratio to its Competitors

Financial Statements
Cytocore Inc's Accounts Receivable	$ 1 Millions	Visit CYOE's Balance sheet
Cytocore Inc's Sales TTM	$ 6 Millions	Visit CYOE's Income Statement
Sources of CYOE's Revenues		Visit CYOE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYOE's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CYOE's Growth Rates	CYOE's Roa	CYOE's Inventory Turnover Ratio	CYOE's Dividend Comparisons
CYOE's Profitability Ratios	CYOE's Roi	CYOE's Asset Turnover Ratio	CYOE's Dividend Growth
CYOE's Valuation Ratios	CYOE's Roe	CYOE's Financial Strength Ratios	CYOE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2014	Receivable at quarter ending Sep 30 2014
Merrimack Pharmaceuticals Inc	11.28	$ 76.674 Millions	$ 6.796 Millions
First Choice Healthcare Solutions Inc	11.27	$ 20.262 Millions	$ 1.797 Millions
Aspira Women s Health inc	11.19	$ 2.548 Millions	$ 0.228 Millions
Procyon Corporation	11.18	$ 2.726 Millions	$ 0.244 Millions
Surmodics Inc	11.13	$ 57.439 Millions	$ 5.162 Millions
Encision Inc	10.93	$ 9.975 Millions	$ 0.913 Millions
Amedisys Inc	10.88	$ 1,197.600 Millions	$ 110.069 Millions
Arbutus Biopharma Corp	10.88	$ 13.566 Millions	$ 1.247 Millions
Corindus Vascular Robotics, Inc.	10.75	$ 1.292 Millions	$ 0.120 Millions
Neurometrix Inc	10.66	$ 5.505 Millions	$ 0.517 Millions
Dendreon Corp	10.61	$ 298.949 Millions	$ 28.166 Millions
Genmark Diagnostics Inc	10.60	$ 27.219 Millions	$ 2.568 Millions
American Caresource Holdings, Inc.	10.52	$ 23.952 Millions	$ 2.277 Millions
National Healthcare Corp	10.43	$ 852.105 Millions	$ 81.680 Millions
Corcept Therapeutics Inc	10.41	$ 21.653 Millions	$ 2.080 Millions
Champions Oncology Inc	10.29	$ 9.941 Millions	$ 0.966 Millions
Heartbeam Inc	10.24	$ 156.030 Millions	$ 15.238 Millions
Sanuwave Health Inc	10.12	$ 0.901 Millions	$ 0.089 Millions
Novavax inc	10.09	$ 32.683 Millions	$ 3.239 Millions
Avid Bioservices Inc	10.00	$ 22.155 Millions	$ 2.217 Millions
Allied Healthcare Products inc	9.97	$ 36.508 Millions	$ 3.662 Millions
Insys Therapeutics, Inc.	9.95	$ 195.811 Millions	$ 19.678 Millions
Sanara Medtech Inc	9.94	$ 2.369 Millions	$ 0.238 Millions
Supernus Pharmaceuticals inc	9.93	$ 101.578 Millions	$ 10.234 Millions
Astrotech Corp	9.91	$ 10.054 Millions	$ 1.015 Millions
Catalent Inc	9.88	$ 1,831.700 Millions	$ 185.400 Millions
Cytosorbents Corporation	9.87	$ 4.128 Millions	$ 0.418 Millions
Chimerix Inc	9.86	$ 3.763 Millions	$ 0.382 Millions
Biolife Solutions Inc	9.77	$ 8.980 Millions	$ 0.919 Millions
Microbot Medical Inc	9.75	$ 0.896 Millions	$ 0.092 Millions

Date modified: 2026-09-08T15:07:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.